Frankfurt - Delayed Quote EUR

Atossa Therapeutics, Inc. (YAG2.F)

Compare
0.8510
+0.1510
+(21.57%)
At close: January 31 at 2:07:53 PM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
--
123,532.0000
141,262.0000
42,839.0000
Total Liabilities Net Minority Interest
--
5,568.0000
3,126.0000
15,671.0000
Total Equity Gross Minority Interest
--
117,964.0000
138,136.0000
27,168.0000
Total Capitalization
--
117,964.0000
138,136.0000
27,168.0000
Preferred Stock Equity
--
--
--
0.0010
Common Stock Equity
--
117,964.0000
138,136.0000
27,168.0000
Capital Lease Obligations
--
--
--
18.0000
Net Tangible Assets
--
117,964.0000
138,136.0000
27,155.0000
Working Capital
--
112,629.0000
138,114.0000
27,099.0000
Invested Capital
--
117,964.0000
138,136.0000
27,168.0000
Tangible Book Value
--
117,964.0000
138,136.0000
27,155.0000
Total Debt
--
--
--
18.0000
Share Issued
126,624.1100
126,624.0000
126,624.0000
47,548.8350
Ordinary Shares Number
125,304.0640
126,624.0000
126,624.0000
47,548.8350
12/31/2020 - 3/27/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers